Table 3 Results of the cost analysis for the introduction of the sFlt-1/PlGF ratio test
From: Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
| Â | No test, n (%) | Test, n (%) | Difference, n |
|---|---|---|---|
Patients hospitalized before preeclampsia, n | 91 | 49 | −42 |
 Subsequently developed preeclampsia, n (%) | 27 (29.6) | 20 (40.8) | −7 |
Patients not hospitalized before preeclampsia, n | 113 | 155 | 42 |
 Subsequently developed preeclampsia, n (%) | 19 (16.8) | 26 (16.7) | 7 |
Total cost, € | |||
 Per cohorta | 161,169 | 87,585 | −73,584 |
 Per patient | 790 | 429 | −361 |